RAPH

Raphael Pharmaceutical Inc.. operates in the medicinal chemicals & botanical products industry. listed on OTC. headquartered in LAS VEGAS, NV.

Raphael Pharmaceutical Inc. (RAPH) is publicly traded on OTC within the Healthcare sector , specifically in the Medicinal Chemicals & Botanical Products industry. The company is headquartered in LAS VEGAS, NV.

Business classification: According to SEC filings, Raphael Pharmaceutical Inc. falls under SIC code 2833 — Medicinal Chemicals & Botanical Products. This classification helps investors compare the company against peers in similar regulatory and operational environments.

Sector outlook: Companies in the Healthcare sector typically share exposure to similar macroeconomic factors — interest rates, regulatory shifts, and consumer demand patterns specific to this industry vertical. Investors evaluating RAPH should benchmark against other Healthcare stocks for comparative analysis.

Industry-specific factors: The Medicinal Chemicals & Botanical Products industry has specific competitive dynamics — market share concentration, supply chain dependencies, and capital intensity that affect valuation. Compare RAPH with peer companies in Medicinal Chemicals & Botanical Products to assess relative positioning.

Regulatory disclosures: With CIK 0001415397, Raphael Pharmaceutical Inc. files mandatory disclosures with the U.S. Securities and Exchange Commission. These include 10-K annual reports, 10-Q quarterly reports, and 8-K material event filings — accessible via the official SEC EDGAR portal for fundamental research.

This page is for educational and research purposes only and does not constitute investment advice. Always conduct independent due diligence and consult a licensed financial advisor before making investment decisions.